Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1985 1
1986 1
1987 2
1992 2
1993 1
1994 1
1995 1
1996 3
1998 2
1999 1
2000 1
2002 1
2003 3
2004 1
2005 3
2006 2
2007 2
2008 2
2009 1
2010 2
2011 3
2013 4
2014 4
2015 5
2016 2
2017 4
2018 8
2019 5
2020 1
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Results by year
Filters applied: . Clear all
Page 1
CD38 in the age of COVID-19: a medical perspective.
Horenstein AL, Faini AC, Malavasi F. Horenstein AL, et al. Physiol Rev. 2021 Oct 1;101(4):1457-1486. doi: 10.1152/physrev.00046.2020. Epub 2021 Mar 31. Physiol Rev. 2021. PMID: 33787351 Free PMC article. Review.
Canonical and non-canonical adenosinergic pathways.
Ferretti E, Horenstein AL, Canzonetta C, Costa F, Morandi F. Ferretti E, et al. Among authors: horenstein al. Immunol Lett. 2019 Jan;205:25-30. doi: 10.1016/j.imlet.2018.03.007. Epub 2018 Mar 14. Immunol Lett. 2019. PMID: 29550257 Review.
Antibody mimicry, receptors and clinical applications.
Horenstein AL, Chillemi A, Quarona V, Zito A, Mariani V, Faini AC, Morandi F, Schiavoni I, Ausiello CM, Malavasi F. Horenstein AL, et al. Hum Antibodies. 2017;25(3-4):75-85. doi: 10.3233/HAB-160305. Hum Antibodies. 2017. PMID: 28035914 Review.
CD38 and bone marrow microenvironment.
Chillemi A, Zaccarello G, Quarona V, Lazzaretti M, Martella E, Giuliani N, Ferracini R, Pistoia V, Horenstein AL, Malavasi F. Chillemi A, et al. Among authors: horenstein al. Front Biosci (Landmark Ed). 2014 Jan 1;19(1):152-62. doi: 10.2741/4201. Front Biosci (Landmark Ed). 2014. PMID: 24389178 Free article. Review.
CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma.
Morandi F, Horenstein AL, Costa F, Giuliani N, Pistoia V, Malavasi F. Morandi F, et al. Among authors: horenstein al. Front Immunol. 2018 Nov 28;9:2722. doi: 10.3389/fimmu.2018.02722. eCollection 2018. Front Immunol. 2018. PMID: 30546360 Free PMC article. Review.
The Key Role of NAD+ in Anti-Tumor Immune Response: An Update.
Morandi F, Horenstein AL, Malavasi F. Morandi F, et al. Among authors: horenstein al. Front Immunol. 2021 Apr 15;12:658263. doi: 10.3389/fimmu.2021.658263. eCollection 2021. Front Immunol. 2021. PMID: 33936090 Free PMC article. Review.
Molecular dynamics of targeting CD38 in multiple myeloma.
Malavasi F, Faini AC, Morandi F, Castella B, Incarnato D, Oliviero S, Horenstein AL, Massaia M, van de Donk NWCJ, Richardson PG. Malavasi F, et al. Among authors: horenstein al. Br J Haematol. 2021 May;193(3):581-591. doi: 10.1111/bjh.17329. Epub 2021 Feb 11. Br J Haematol. 2021. PMID: 33570193
Monoclonal antibodies in clinical applications.
Funaro A, Horenstein AL, Malavasi F. Funaro A, et al. Among authors: horenstein al. J Biol Regul Homeost Agents. 1996 Oct-Dec;10(4):72-82. J Biol Regul Homeost Agents. 1996. PMID: 9604775 Review. No abstract available.
66 results